市場調查報告書
商品編碼
1395088
褪黑激素產品市場規模 - 按類型(天然褪黑激素、合成褪黑激素)按應用(醫療、膳食補充劑)按形式(丸劑、咀嚼片、液體、噴霧劑)、按分銷(藥房、線上零售)與全球預測,2023-2032 年Melatonin Products Market Size - By Type (Natural melatonin, Synthetic melatonin) By Application (Medical, Dietary supplements) By Form (Pills, Chewable, Liquid, Sprays), By Distribution (Pharmacies, Online retail), & Global Forecast, 2023-2032 |
由於全球睡眠障礙盛行率不斷上升,預計 2023 年至 2032 年褪黑激素產品市場規模將以超過 14.3% 的CAGR擴大。
失眠、睡眠呼吸中止症和晝夜節律紊亂等睡眠狀況的激增推動了對幾種自然療法的需求。此外,壓力水平的上升、工作時間的延長以及電子設備的普遍使用都導致睡眠模式被破壞,進一步促使人們尋求有效的解決方案。產業參與者越來越關注滿足對有效的褪黑激素注入解決方案不斷成長的需求,以解決與睡眠相關的問題,這將增強產業前景。例如,2023年11月,PharmaLinea推出了基於褪黑激素及其專利成分Qnight的新型臨床保證膳食補充劑,以幫助改善睡眠品質和急性睡眠潛伏期。
褪黑激素產品產業分為類型、應用、形式、配銷通路和地區。
根據類型,由於消費者對天然助眠劑的偏好不斷增加,預計天然褪黑激素產品市場從 2023 年到 2032 年的CAGR將超過 12%。源自植物(例如酸櫻桃)的天然褪黑激素補充劑因其公認的健康益處和最小的副作用而受到關注。此外,越來越多的消費者尋求非合成替代品來支持睡眠,這將推動對天然褪黑激素產品的需求。
就應用而言,到2032年,醫療領域褪黑素產品市場的成長率可能會超過14%。這可以歸因於褪黑素的治療潛力擴大被使用。此外,褪黑激素的神經保護和抗氧化特性也有助於其在治療某些醫療狀況中的越來越多的應用。此外,正在進行的研發活動旨在發現褪黑激素的多種醫療功效,這將促進該領域的成長。
從地區來看,隨著睡眠相關問題在該地區日益普遍,亞太地區褪黑激素產品市場預計在 2023 年至 2032 年間以 13.6% 的成長率擴張。中國、印度和日本等國家對褪黑激素產品的需求正在激增,以滿足尋求傳統睡眠輔助品替代品的注重健康的消費者的需求。
此外,對褪黑素飲料、補充劑和美容產品等多種配方的需求不斷成長,為行業參與者提供了潛在的成長機會,從而加速了區域產業的擴張。例如,2022年12月,澳洲保健食品公司梅爾羅斯健康集團宣布計畫以新的市場策略和新的產品線拓展中國市場,其中包括推出結合玻尿酸、褪黑素和蝦紅素的美容睡眠產品。
Melatonin Products Market size is projected to expand at over 14.3% CAGR from 2023-2032 due to the rising prevalence of sleep disorders globally.
The surge in sleep conditions, such as insomnia, sleep apnea, and circadian rhythm disruptions is propelling the demand for several natural remedies. Additionally, the rising stress levels, longer working hours, and the pervasive usage of electronic devices are contributing to disrupted sleep patterns, further leading individuals to seek effective solutions. The growing focus of industry participants on catering to the rising demand for effective melatonin-infused solutions to address the sleep-related issues will augment the industry outlook. For instance, in November 2023, PharmaLinea launched a new clinically guaranteed dietary supplement based on melatonin and its patented component, Qnight to help with sleep quality and acute sleep latency.
The melatonin products industry is segmented into type, application, form, distribution channel, and region.
Based on type, the natural melatonin products market is anticipated to observe over 12% CAGR from 2023-2032 owing to the increasing consumer preference for natural sleep aids. Natural melatonin supplements sourced from plants, such as tart cherries are gaining prominence due to their perceived health benefits and minimal side effects. Furthermore, the rising number of consumers seeking non-synthetic alternatives for sleep support will push the demand for natural melatonin products.
With respect to application, the melatonin products market from the medical segment is likely to record over 14% growth rate through 2032. This can be attributed to the increasing use of melatonin for its therapeutic potential. Additionally, the neuroprotective and antioxidant properties of melatonin are contributing to its increasing use in managing certain medical conditions. Moreover, the ongoing R&D initiatives to discover the diverse medical benefits of melatonin will boost the segment growth.
Regionally, the Asia Pacific melatonin products market is poised to expand at 13.6% growth rate between 2023 and 2032 with sleep-related issues becoming increasingly prevalent across the region. Countries like China, India, and Japan are experiencing surging demand for melatonin products to cater to health-conscious consumers seeking alternatives to traditional sleep aids.
Furthermore, the surging need for diverse formulations, such as melatonin-infused beverages, supplements, and beauty products are providing potential growth opportunities to the industry participants, thereby accelerating the regional industry expansion. For instance, in December 2022, Melrose Health Group, an Australian health foods firm, announced plans to expand in China with a new market strategy and new product pipeline, including the launch of a beauty sleep product by combining hyaluronic acid, melatonin, and astaxanthin.